Success Metrics

Clinical Success Rate

75.0%

Based on 3 completed trials

Completion Rate

75%(3/4)

Active Trials

0(0%)

Results Posted

0%(0 trials)

Terminated

1(20%)

Phase Distribution

Ph phase_1

20%

Ph phase_2

80%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution5 total trials

Phase 1Safety & dosage

1(20.0%)

Phase 2Efficacy & side effects

4(80.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

60.0%

3 of 5 finished

Non-Completion Rate

40.0%

2 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(3)

Terminated(2)

Detailed Status

Completed3

Terminated1

Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

75.0%

Most Advanced

Phase 2

Trials by Phase

Phase 11 (20.0%)

Phase 24 (80.0%)

Trials by Status

completed360%

terminated120%

withdrawn120%

Recent Activity

0 active trials

Showing 5 of 5

terminatedphase_2

Safety and Efficacy Study of BMS-823778 to Treat Uncontrolled High Blood Pressure in Overweight and Obese Patients

NCT01602367

completedphase_2

Clinical Trials (5)

Showing 5 of 5 trials

NCT01602367Phase 2

Safety and Efficacy Study of BMS-823778 to Treat Uncontrolled High Blood Pressure in Overweight and Obese Patients

Terminated

NCT01111955Phase 2

Safety Study of BMS-823778 in Subjects With Type 2 Diabetes

Completed

NCT01112423Phase 2

Safety Study of BMS-823778 in Subjects With Hypercholesterolemia

Completed

NCT01666704Phase 2

Proof of Concept Study of BMS-823778 to Assess the Effects on Atherosclerosis

Withdrawn

NCT01515202Phase 1

Japanese Phase 1 Multiple Ascending Dose Study

Completed

All 5 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 5